Dopaminergic agonists and L-DOPA, used to treat Parkinson’s disease, induce dopamine receptor expression on immune cells

Authors

  • Gloria Erandi Pérez Figueroa Instituto Nacional de Neurología y Neurocirugía
  • Adrian Guevara-Salinas 1Laboratorio de Neuroinflamación, Unidad Periférica para el estudio de la Neuroinflamación, Instituto de Investigaciones Biomédicas en el Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez
  • Diana Álvarez -Luquín Laboratorio de Neuroinflamación, Unidad Periférica para el estudio de la Neuroinflamación, Instituto de Investigaciones Biomédicas en el Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez
  • Laura Adalid Peralta Laboratorio de Neuroinflamación, Unidad Periférica para el estudio de la Neuroinflamación, Instituto de Investigaciones Biomédicas en el Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez

Keywords:

Dopaminergic agonists, immune cells, Parkinson Disease

Additional Files

Published

2024-04-23

How to Cite

Pérez Figueroa, G. E., Guevara-Salinas , A., Álvarez -Luquín , D., & Adalid Peralta, L. (2024). Dopaminergic agonists and L-DOPA, used to treat Parkinson’s disease, induce dopamine receptor expression on immune cells. Archivos De Neurociencias, 29(S1). Retrieved from https://archivosdeneurociencias.org/index.php/ADN/article/view/518

Issue

Vol. 29 No. S1 (2024): Annual Research Meeting from the National Institute of Neurology and Neurosurgery Manuel Velasco Suárez

Section

Conference proceedings

License

Copyright (c) 2023 Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

September 2022-present © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.

January-September 2022 © The authors. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.

January 2014-December 2021 © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.